Raffles Medical's (SGX:BSL) attributable profit rose 4.3% in the second half of 2024 to SG$31.6 million from SG$30.3 million a year earlier, according to a filing with the Singapore Exchange on Monday.
Earnings per share climbed to SG$0.017 from SG$0.0162 in the comparable period.
Revenue was up 15% year over year to SG$385.9 million from SG$336.2 million, mainly due to improved performance from the hospital services division.
The group declared a final dividend of SG$0.025 per share.
Shares of the medical services company were up over 6% in recent trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.